Effects of Dexamethasone on Hepatic Ischemia-reperfusion Injuries

Ischemia-reperfusion injuries (IRI) are the major causes of liver failure after various types of liver surgeries such as biopsy, transplantation, and tumor surgery. Its pathogenesis is multifactorial and complex that involves ATP depletion, hepatocyte edema, acidosis, oxidative stress, inflammation,...

Full description

Bibliographic Details
Main Authors: Vahid Akbari Kordkheyli, Setareh Zarpou, Pooneh yazdani, Abbas Khonakdar Tarsi
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences 2017-12-01
Series:Journal of Mazandaran University of Medical Sciences
Subjects:
Online Access:http://jmums.mazums.ac.ir/article-1-10293-en.html
_version_ 1797943704207491072
author Vahid Akbari Kordkheyli
Setareh Zarpou
Pooneh yazdani
Abbas Khonakdar Tarsi
author_facet Vahid Akbari Kordkheyli
Setareh Zarpou
Pooneh yazdani
Abbas Khonakdar Tarsi
author_sort Vahid Akbari Kordkheyli
collection DOAJ
description Ischemia-reperfusion injuries (IRI) are the major causes of liver failure after various types of liver surgeries such as biopsy, transplantation, and tumor surgery. Its pathogenesis is multifactorial and complex that involves ATP depletion, hepatocyte edema, acidosis, oxidative stress, inflammation, and microcirculation defect which can eventually progress to liver cell death, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome, and even acute graft rejection. There are much evidences that suggest applying anti-inflammatory drugs could be a proper strategy to decrease IRI. Dexamethasone is a highly potent synthetic corticosteroid that its beneficial effects on various tissues in IRI are well documented. It also suppresses inflammation and immune response in different pathologic conditions. Its functional mechanism is different in various types of cells and involves: inactivation of NF-κB and AP-1, inhibition of releasing PLA2 and arachidonic acid, and induction of ERK1/2 and SGK-1. By these processes dexamethasone is able to prevent cytokine overproduction and leukocyte activation, recruitment and infiltration. In this review, we aimed to explain the protective effects of dexamethasone on liver ischemia-reperfusion injuries.
first_indexed 2024-04-10T20:28:24Z
format Article
id doaj.art-455b3fe15d2c4c678d10e8e13e465ed8
institution Directory Open Access Journal
issn 1735-9260
1735-9279
language English
last_indexed 2024-04-10T20:28:24Z
publishDate 2017-12-01
publisher Mazandaran University of Medical Sciences
record_format Article
series Journal of Mazandaran University of Medical Sciences
spelling doaj.art-455b3fe15d2c4c678d10e8e13e465ed82023-01-25T07:43:27ZengMazandaran University of Medical SciencesJournal of Mazandaran University of Medical Sciences1735-92601735-92792017-12-0127155196209Effects of Dexamethasone on Hepatic Ischemia-reperfusion InjuriesVahid Akbari Kordkheyli0Setareh Zarpou1Pooneh yazdani2Abbas Khonakdar Tarsi3 MSc Student in Biochemistry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran MSc Student in Biochemistry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran Ischemia-reperfusion injuries (IRI) are the major causes of liver failure after various types of liver surgeries such as biopsy, transplantation, and tumor surgery. Its pathogenesis is multifactorial and complex that involves ATP depletion, hepatocyte edema, acidosis, oxidative stress, inflammation, and microcirculation defect which can eventually progress to liver cell death, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome, and even acute graft rejection. There are much evidences that suggest applying anti-inflammatory drugs could be a proper strategy to decrease IRI. Dexamethasone is a highly potent synthetic corticosteroid that its beneficial effects on various tissues in IRI are well documented. It also suppresses inflammation and immune response in different pathologic conditions. Its functional mechanism is different in various types of cells and involves: inactivation of NF-κB and AP-1, inhibition of releasing PLA2 and arachidonic acid, and induction of ERK1/2 and SGK-1. By these processes dexamethasone is able to prevent cytokine overproduction and leukocyte activation, recruitment and infiltration. In this review, we aimed to explain the protective effects of dexamethasone on liver ischemia-reperfusion injuries.http://jmums.mazums.ac.ir/article-1-10293-en.htmlischemiareperfusiondexamethasoneinflammation
spellingShingle Vahid Akbari Kordkheyli
Setareh Zarpou
Pooneh yazdani
Abbas Khonakdar Tarsi
Effects of Dexamethasone on Hepatic Ischemia-reperfusion Injuries
Journal of Mazandaran University of Medical Sciences
ischemia
reperfusion
dexamethasone
inflammation
title Effects of Dexamethasone on Hepatic Ischemia-reperfusion Injuries
title_full Effects of Dexamethasone on Hepatic Ischemia-reperfusion Injuries
title_fullStr Effects of Dexamethasone on Hepatic Ischemia-reperfusion Injuries
title_full_unstemmed Effects of Dexamethasone on Hepatic Ischemia-reperfusion Injuries
title_short Effects of Dexamethasone on Hepatic Ischemia-reperfusion Injuries
title_sort effects of dexamethasone on hepatic ischemia reperfusion injuries
topic ischemia
reperfusion
dexamethasone
inflammation
url http://jmums.mazums.ac.ir/article-1-10293-en.html
work_keys_str_mv AT vahidakbarikordkheyli effectsofdexamethasoneonhepaticischemiareperfusioninjuries
AT setarehzarpou effectsofdexamethasoneonhepaticischemiareperfusioninjuries
AT poonehyazdani effectsofdexamethasoneonhepaticischemiareperfusioninjuries
AT abbaskhonakdartarsi effectsofdexamethasoneonhepaticischemiareperfusioninjuries